Gene · 5214
Papers1,761
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,761
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unraveling the Sweet Secrets of HCC: Glucometabolic Rewiring in Hepatocellular Carcinoma. | Technol Cancer Res Treat | 2023 | 38083797 | PubTator, text mining | PubMed |
| USP7 promotes non-small-cell lung cancer cell glycolysis and survival by stabilizing and activating c-Abl. | Clin Transl Med | 2023 | 38082439 | PubTator, text mining | PubMed |
| Patterns of Gene Expression, Splicing, and Allele-Specific Expression Vary among Macular Tissues and Clinical Stages of Age-Related Macular Degeneration. | Cells | 2023 | 38067097 | PubTator, text mining | PubMed |
| Gut liver brain axis in diseases: the implications for therapeutic interventions. | Signal Transduct Target Ther | 2023 | 38057297 | PubTator, text mining | PubMed |
| Macrophage LMO7 deficiency facilitates inflammatory injury via metabolic-epigenetic reprogramming. | Acta Pharm Sin B | 2023 | 38045056 | PubTator, text mining | PubMed |
| Potential therapies targeting nuclear metabolic regulation in cancer. | MedComm (2020) | 2023 | 38034101 | PubTator, text mining | PubMed |
| Serum protein biomarkers for HCC risk prediction in HIV/HBV co-infected people: a clinical proteomic study using mass spectrometry. | Front Immunol | 2023 | 38022651 | PubTator, text mining | PubMed |
| Editorial: Studying novel immune signatures, targets, and drugs in hepatobiliary tumors: based on advanced technologies. | Front Immunol | 2023 | 38022560 | PubTator, text mining | PubMed |
| Stromal-Modulated Epithelial-to-Mesenchymal Transition in Cancer Cells. | Biomolecules | 2023 | 38002286 | PubTator, text mining | PubMed |
| SETD2 deficiency accelerates sphingomyelin accumulation and promotes the development of renal cancer. | Nat Commun | 2023 | 37989747 | PubTator, text mining | PubMed |
| Big data analysis identified a telomere-related signature predicting the prognosis and drug sensitivity in lung adenocarcinoma. | Medicine (Baltimore) | 2023 | 37986388 | PubTator, text mining | PubMed |
| Synergistic suppressive effects on triple-negative breast cancer by the combination of JTC-801 and sodium oxamate. | Am J Cancer Res | 2023 | 37970352 | PubTator, text mining | PubMed |
| p53-responsive CMBL reprograms glucose metabolism and suppresses cancer development by destabilizing phosphofructokinase PFKP. | Cell Rep | 2023 | 37967006 | PubTator, text mining | PubMed |
| The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approaches. | Basic Res Cardiol | 2023 | 37938421 | PubTator, text mining | PubMed |
| The Impact and Burden of Dietary Sugars on the Liver. | Hepatol Commun | 2023 | 37930128 | PubTator, text mining | PubMed |
| Mitochondrial regulation in human pluripotent stem cells during reprogramming and β cell differentiation. | Front Endocrinol (Lausanne) | 2023 | 37929027 | PubTator, text mining | PubMed |
| A molecular classification system for estimating radiotherapy response and anticancer immunity for individual breast cancer patients. | Front Oncol | 2023 | 37927478 | PubTator, text mining | PubMed |
| Preadipocytes in human granulation tissue: role in wound healing and response to macrophage polarization. | Inflamm Regen | 2023 | 37904253 | PubTator, text mining | PubMed |
Interaction of the C9orf72-Amyotrophic Lateral Sclerosis-Related Proline-Arginine Dipeptide Repeat Protein with the RNA-Binding Protein NOVA1 Causes Decreased Expression of UNC13A Due to Enhanced Inclusion of Cryptic Exons, Which Is Reversed by Betulin Treatment. | Cells | 2023 | 37887320 | PubTator, text mining | PubMed |
| circPSD3 is a promising inhibitor of uPA system to inhibit vascular invasion and metastasis in hepatocellular carcinoma. | Mol Cancer | 2023 | 37884951 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5214/papers?page=10